JP2022511122A5 - - Google Patents
Info
- Publication number
- JP2022511122A5 JP2022511122A5 JP2021542081A JP2021542081A JP2022511122A5 JP 2022511122 A5 JP2022511122 A5 JP 2022511122A5 JP 2021542081 A JP2021542081 A JP 2021542081A JP 2021542081 A JP2021542081 A JP 2021542081A JP 2022511122 A5 JP2022511122 A5 JP 2022511122A5
- Authority
- JP
- Japan
- Prior art keywords
- note
- composition
- therapeutic composition
- approximately
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862739844P | 2018-10-01 | 2018-10-01 | |
| US62/739,844 | 2018-10-01 | ||
| US201962845858P | 2019-05-09 | 2019-05-09 | |
| US201962845859P | 2019-05-09 | 2019-05-09 | |
| US62/845,858 | 2019-05-09 | ||
| US62/845,859 | 2019-05-09 | ||
| PCT/US2019/054044 WO2020072479A1 (en) | 2018-10-01 | 2019-10-01 | Therapeutic compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511122A JP2022511122A (ja) | 2022-01-28 |
| JP2022511122A5 true JP2022511122A5 (enExample) | 2022-10-06 |
| JP7608342B2 JP7608342B2 (ja) | 2025-01-06 |
Family
ID=70055829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542081A Active JP7608342B2 (ja) | 2018-10-01 | 2019-10-01 | 治療用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US12324797B2 (enExample) |
| EP (2) | EP3860585A4 (enExample) |
| JP (1) | JP7608342B2 (enExample) |
| KR (1) | KR102894256B1 (enExample) |
| CN (2) | CN113164420B (enExample) |
| AU (3) | AU2019355862B2 (enExample) |
| BR (1) | BR112021006288A2 (enExample) |
| CA (1) | CA3178309A1 (enExample) |
| MX (1) | MX2021003810A (enExample) |
| WO (2) | WO2020072479A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018148763A1 (en) | 2017-02-13 | 2018-08-16 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
| CN113164420B (zh) * | 2018-10-01 | 2025-01-03 | 温特穆特生物医学公司 | 治疗组合物 |
| US12414928B2 (en) | 2021-05-14 | 2025-09-16 | Rene Dumalaog Javier | Viral inactivation spray and gargling formulation |
| WO2022241303A1 (en) * | 2021-05-14 | 2022-11-17 | University Of South Florida | Composition and method for treating covid-19 |
| AU2022277023A1 (en) * | 2021-05-18 | 2024-01-18 | Ecochem Australia Pty Ltd | Sanitising systems and methods |
| CN113583454A (zh) * | 2021-08-16 | 2021-11-02 | 河南迪怡疗护科技开发有限公司 | 抗菌型医用材料、抗菌型医疗器械 |
| BR102022016500A2 (pt) * | 2022-08-18 | 2024-02-27 | Universidade Estadual De Campinas | Processo de obtenção de composições à base de compostos multifuncionais, composições à base de compostos multifuncionais assim obtidas e seu uso |
| CN117064911A (zh) * | 2023-02-28 | 2023-11-17 | 沈阳药科大学 | 一种pd-l2抑制剂及其在制备抑制肿瘤细胞pd-l2的药物中的用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
| US4147769A (en) * | 1976-06-28 | 1979-04-03 | Nelson Research & Development Company | Microbicidal composition |
| GB2051574B (en) | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
| US5260066A (en) | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
| US5776913A (en) | 1995-10-10 | 1998-07-07 | Colgate Palmolive Company | Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
| US6015798A (en) | 1995-10-10 | 2000-01-18 | Colgate Palmolive Company | Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| US5766614A (en) | 1997-03-20 | 1998-06-16 | Yong; Liu | Burn treatment compositions containing herbal mix |
| JPH11269034A (ja) | 1998-03-20 | 1999-10-05 | Shiseido Co Ltd | ニキビ改善用皮膚外用剤 |
| US6407278B2 (en) | 1998-11-16 | 2002-06-18 | Medimmune Oncology, Inc. | Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| JP2000281528A (ja) | 1999-03-31 | 2000-10-10 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
| US6696081B2 (en) | 2000-06-09 | 2004-02-24 | Duke University | Carbohydrate based lipid compositions and supramolecular structures comprising same |
| US6841174B2 (en) | 2000-09-20 | 2005-01-11 | Zeyad Technologies Llc | Herbal compositions and treatment methods |
| JP2002114670A (ja) | 2000-10-02 | 2002-04-16 | Noevir Co Ltd | 抗菌性皮膚外用剤 |
| US7288265B1 (en) | 2000-10-16 | 2007-10-30 | Lectec Corporation | Treating viral infection at smallpox vaccination site |
| GB0221697D0 (en) | 2002-09-18 | 2002-10-30 | Unilever Plc | Novel compouds and their uses |
| IL152486A0 (en) * | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| ATE529094T1 (de) | 2003-01-27 | 2011-11-15 | Vitamin C60 Biores Corp | Zusammensetzung zur äusseren anwendung |
| MXPA05009933A (es) | 2003-03-18 | 2005-11-04 | Novartis Ag | Composiciones que comprenden acidos grasos y aminoacidos. |
| CA2529125A1 (en) | 2003-06-19 | 2004-12-23 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| CN100582089C (zh) | 2003-11-21 | 2010-01-20 | 吉万奥丹股份有限公司 | N-取代的对-薄荷烷甲酰胺 |
| US20120328544A1 (en) | 2003-12-22 | 2012-12-27 | Nevada Naturals, Inc. | Dermatological Treatment Methods And Formulations |
| JP4927718B2 (ja) | 2004-06-18 | 2012-05-09 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | ブラックベリー抽出物 |
| EP1796656A2 (en) | 2004-09-17 | 2007-06-20 | Oystershell NV | Composition for inhibiting or preventing the formation of a biofilm |
| GB0423652D0 (en) | 2004-10-25 | 2004-11-24 | Univ Coventry | Kit |
| AU2006298442A1 (en) | 2005-05-09 | 2007-04-12 | Foamix Ltd. | Saccharide foamable compositions |
| EP1842437A1 (en) | 2006-04-06 | 2007-10-10 | Purac Biochem BV | Antimicrobial preparations |
| US20080026974A1 (en) | 2006-07-27 | 2008-01-31 | Barnhart Ronald A | Antimicrobial hand wash |
| CN1969984B (zh) | 2006-12-07 | 2010-12-29 | 刘爱芹 | 一种治疗皮肤粉刺和过敏的外用药 |
| US8669045B2 (en) | 2007-02-13 | 2014-03-11 | Ajinomoto Co., Inc. | Method for inactivating viruses with slightly acidic arginine |
| JP2008208059A (ja) | 2007-02-26 | 2008-09-11 | Green Products Laboratory Ltd | 糖ウンデシレン酸エステルを含有する皮膚外用剤 |
| MY149924A (en) | 2007-03-09 | 2013-10-31 | Otsuka Pharma Co Ltd | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| US8623335B2 (en) | 2007-09-10 | 2014-01-07 | Tauna Ann Waddington | Scar and rosacea and other skin care treatment composition and method |
| US20110105386A1 (en) * | 2008-01-16 | 2011-05-05 | Technion Research & Development Foundation Ltd. | Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents |
| US20110034557A1 (en) * | 2009-02-20 | 2011-02-10 | Modular Genetics, Inc. | Antimicrobial compositions and uses thereof |
| CN101991726A (zh) | 2009-08-25 | 2011-03-30 | 肖华 | 一种治疗巨细胞病毒的药物组合物及其制备方法 |
| WO2011105633A1 (en) | 2010-02-26 | 2011-09-01 | Ajinomoto Co., Inc. | Virus-inactivating composition containing low-molecular weight compound and arginine |
| CN107648341A (zh) | 2010-12-28 | 2018-02-02 | 卡梅迪斯有限公司 | 用于治疗和预防感染的植物提取物 |
| CN102178842B (zh) | 2011-04-27 | 2013-10-16 | 李梅华 | 一种治疗结核病的药物组合物及应用 |
| PT2948129T (pt) * | 2013-01-25 | 2018-02-12 | Wintermute Biomedical Inc | Compostos terapêuticos |
| BR112017002858B1 (pt) | 2014-08-13 | 2022-01-18 | Akeso Biomedical, Inc | Método não terapêutico para aumentar o crescimento de um animal, uso não terapêutico de um ou mais compostos, um ou mais compostos, animal não humano ou produto animal, alimento para animais adequado para uso e suprimento de água potável para animais adequado para uso |
| WO2018148763A1 (en) * | 2017-02-13 | 2018-08-16 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
| US10894788B2 (en) | 2018-06-29 | 2021-01-19 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinases |
| CN113164420B (zh) | 2018-10-01 | 2025-01-03 | 温特穆特生物医学公司 | 治疗组合物 |
-
2019
- 2019-10-01 CN CN201980077648.XA patent/CN113164420B/zh active Active
- 2019-10-01 US US17/282,185 patent/US12324797B2/en active Active
- 2019-10-01 AU AU2019355862A patent/AU2019355862B2/en active Active
- 2019-10-01 KR KR1020217012752A patent/KR102894256B1/ko active Active
- 2019-10-01 JP JP2021542081A patent/JP7608342B2/ja active Active
- 2019-10-01 WO PCT/US2019/054044 patent/WO2020072479A1/en not_active Ceased
- 2019-10-01 BR BR112021006288A patent/BR112021006288A2/pt unknown
- 2019-10-01 EP EP19869613.0A patent/EP3860585A4/en active Pending
- 2019-10-01 CN CN202411873062.3A patent/CN119656321A/zh active Pending
- 2019-10-01 MX MX2021003810A patent/MX2021003810A/es unknown
-
2020
- 2020-03-31 US US16/836,893 patent/US11154524B2/en active Active
- 2020-03-31 US US16/836,881 patent/US11103475B2/en active Active
-
2021
- 2021-03-31 CA CA3178309A patent/CA3178309A1/en active Pending
- 2021-03-31 WO PCT/US2021/025060 patent/WO2021202644A1/en not_active Ceased
- 2021-03-31 AU AU2021248831A patent/AU2021248831A1/en active Pending
- 2021-03-31 EP EP21779127.6A patent/EP4125815A4/en active Pending
- 2021-07-20 AU AU2021206820A patent/AU2021206820B2/en active Active
- 2021-08-30 US US17/461,857 patent/US12383524B2/en active Active
- 2021-10-25 US US17/510,326 patent/US12186293B2/en active Active
-
2025
- 2025-01-06 US US19/011,583 patent/US20250241883A1/en active Pending
- 2025-04-28 US US19/192,157 patent/US20250345303A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| JP2016535781A5 (enExample) | ||
| EA202092343A1 (ru) | Лечение гнойного гидраденита с использованием ингибиторов jak | |
| JP2019519519A5 (enExample) | ||
| MX2020008258A (es) | Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos. | |
| JP5377326B2 (ja) | ウシ類と他の動物における炎症を処置するための薬学的組成物および方法 | |
| Altinoz et al. | Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones | |
| García et al. | Self-assembled nanomaterials | |
| EA201590166A8 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| EA201290865A1 (ru) | Применение леводопы, карбидопы и энтакапона для лечения болезни паркинсона | |
| BR112015028692A8 (pt) | agente preventivo ou terapêutico para mastite de animal ruminante | |
| JP2019517587A5 (enExample) | ||
| CN111989095A (zh) | 预防或治疗肿瘤疗法副作用的方法 | |
| WO2020072601A1 (en) | Pharmaceutical compositions comprising otic therapeutic agents and related methods | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2018509388A5 (enExample) | ||
| JP2014505061A5 (enExample) | ||
| JP2017533972A5 (enExample) | ||
| JP2019515909A5 (enExample) | ||
| JOP20180127A1 (ar) | صيغ صلبة من منشط محلقة غوانيليل قابل للذوبان (sGC) | |
| Perepa et al. | Diclofenac transdermal patch: A potential ingress to maxillofacial surgery | |
| MX2023003332A (es) | Inhibidores del elemento 1 interdispersado largo (line-1) para el tratamiento de enfermedades. | |
| MX2021015447A (es) | Métodos de tratamiento del cáncer dirigidos a tumores fríos. | |
| MX2023009600A (es) | Análogos de la oxa-ibogaína para el tratamiento de trastornos por consumo de sustancias. | |
| RU2014106867A (ru) | Сложные эфиры пентамидин-амидоксим кислот как пролекарства и их применение в качестве лекарственных средств |